ES2568955T3 - Microorganismos metabólicamente activos y métodos para su producción - Google Patents
Microorganismos metabólicamente activos y métodos para su producción Download PDFInfo
- Publication number
- ES2568955T3 ES2568955T3 ES05786983.6T ES05786983T ES2568955T3 ES 2568955 T3 ES2568955 T3 ES 2568955T3 ES 05786983 T ES05786983 T ES 05786983T ES 2568955 T3 ES2568955 T3 ES 2568955T3
- Authority
- ES
- Spain
- Prior art keywords
- bacteria
- preparation
- range
- growth substrate
- total amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 74
- 244000005700 microbiome Species 0.000 title claims description 38
- 238000004519 manufacturing process Methods 0.000 title claims description 24
- 230000012010 growth Effects 0.000 claims abstract description 142
- 241000894006 Bacteria Species 0.000 claims abstract description 132
- 238000002360 preparation method Methods 0.000 claims abstract description 101
- 239000000758 substrate Substances 0.000 claims abstract description 96
- 239000000203 mixture Substances 0.000 claims abstract description 41
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 35
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 33
- 235000000346 sugar Nutrition 0.000 claims abstract description 31
- 150000008163 sugars Chemical class 0.000 claims abstract description 31
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 17
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 16
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 16
- 241000194031 Enterococcus faecium Species 0.000 claims abstract description 13
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 13
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 11
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 11
- 150000002772 monosaccharides Chemical class 0.000 claims abstract description 11
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 11
- 150000004676 glycans Chemical class 0.000 claims abstract description 10
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 10
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 10
- 239000005017 polysaccharide Substances 0.000 claims abstract description 10
- 241000894007 species Species 0.000 claims description 26
- 238000003860 storage Methods 0.000 claims description 21
- 230000000813 microbial effect Effects 0.000 claims description 11
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 230000000968 intestinal effect Effects 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 229940121375 antifungal agent Drugs 0.000 claims description 7
- 239000003429 antifungal agent Substances 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- 230000001684 chronic effect Effects 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 3
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 239000002253 acid Substances 0.000 abstract description 5
- 150000002016 disaccharides Chemical class 0.000 abstract description 3
- 235000013339 cereals Nutrition 0.000 description 35
- 230000001580 bacterial effect Effects 0.000 description 29
- 239000006041 probiotic Substances 0.000 description 26
- 235000018291 probiotics Nutrition 0.000 description 26
- 150000001720 carbohydrates Chemical class 0.000 description 24
- 235000014633 carbohydrates Nutrition 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 23
- 238000002803 maceration Methods 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 230000008569 process Effects 0.000 description 16
- 235000021309 simple sugar Nutrition 0.000 description 15
- 230000000529 probiotic effect Effects 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 12
- 235000015097 nutrients Nutrition 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 241000271566 Aves Species 0.000 description 10
- 235000010633 broth Nutrition 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 235000021310 complex sugar Nutrition 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 239000004464 cereal grain Substances 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 239000003833 bile salt Substances 0.000 description 8
- 229940093761 bile salts Drugs 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 241000287828 Gallus gallus Species 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 230000001332 colony forming effect Effects 0.000 description 6
- 230000035784 germination Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000009630 liquid culture Methods 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 230000035899 viability Effects 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000013405 beer Nutrition 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000013330 chicken meat Nutrition 0.000 description 5
- 244000005709 gut microbiome Species 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 5
- 229940038773 trisodium citrate Drugs 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000194033 Enterococcus Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- 230000000284 resting effect Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000007407 health benefit Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004890 malting Methods 0.000 description 3
- 230000002906 microbiologic effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000004302 potassium sorbate Substances 0.000 description 3
- 235000010241 potassium sorbate Nutrition 0.000 description 3
- 229940069338 potassium sorbate Drugs 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 235000019801 trisodium phosphate Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 241000609240 Ambelania acida Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 241000272534 Struthio camelus Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000010905 bagasse Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000013124 brewing process Methods 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- -1 for example Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- ONXOKWFYBIQOFQ-VSXSCALHSA-N ac1l4s0d Chemical compound OS(O)(=O)=O.O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O.O[C@@H]1[C@H](O)[C@@H](O)[C@@H](SC)O[C@@H]1[C@@H]([C@@H](C)O)NC(=O)[C@H]1N(C)C[C@H](C(C)C)C1 ONXOKWFYBIQOFQ-VSXSCALHSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 235000005550 amino acid supplement Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000012152 bradford reagent Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012543 microbiological analysis Methods 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 210000001325 yolk sac Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0421448 | 2004-09-27 | ||
| GB0421448A GB2418431A (en) | 2004-09-27 | 2004-09-27 | Metabolically active micro organisms and methods for their production |
| PCT/GB2005/003715 WO2006035218A1 (en) | 2004-09-27 | 2005-09-27 | Metabolically active micro organisms and methods for their production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2568955T3 true ES2568955T3 (es) | 2016-05-05 |
Family
ID=33397330
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES05786983.6T Active ES2568955T3 (es) | 2004-09-27 | 2005-09-27 | Microorganismos metabólicamente activos y métodos para su producción |
| ES16155521.4T Active ES2654246T3 (es) | 2004-09-27 | 2005-09-27 | Probióticos metabólicamente activos |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16155521.4T Active ES2654246T3 (es) | 2004-09-27 | 2005-09-27 | Probióticos metabólicamente activos |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8551473B2 (enExample) |
| EP (2) | EP1794283B1 (enExample) |
| JP (1) | JP5577020B2 (enExample) |
| CN (2) | CN100537740C (enExample) |
| AU (1) | AU2005288751B2 (enExample) |
| CA (1) | CA2580949C (enExample) |
| EA (1) | EA012968B1 (enExample) |
| ES (2) | ES2568955T3 (enExample) |
| GB (1) | GB2418431A (enExample) |
| NO (1) | NO20072210L (enExample) |
| NZ (1) | NZ553858A (enExample) |
| PL (2) | PL3050960T3 (enExample) |
| WO (1) | WO2006035218A1 (enExample) |
| ZA (1) | ZA200702398B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2418431A (en) * | 2004-09-27 | 2006-03-29 | Multigerm Uk Entpr Ltd | Metabolically active micro organisms and methods for their production |
| SE532899C2 (sv) | 2007-06-08 | 2010-05-04 | Probi Ab | Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel |
| BRPI0823218A2 (pt) * | 2008-11-21 | 2014-10-14 | Jose Antonio Cruz Serrano | Método para obter uma mistura de probióticos, prebióticos nutrientes com ação simbiótica sinergística |
| GB201119774D0 (en) * | 2011-11-16 | 2011-12-28 | Multigerm Uk Entpr Ltd | IBS treatment |
| WO2013072654A1 (en) | 2011-11-16 | 2013-05-23 | Multigerm Uk Enterprises Ltd. | Ibs treatment |
| GB201219873D0 (en) * | 2012-11-05 | 2012-12-19 | Multigerm Uk Entpr Ltd | Diverticulitis treatment |
| DE102012110612A1 (de) * | 2012-11-06 | 2014-05-08 | Gelita Ag | Kollagenhydrolysat und dessen Verwendung |
| CN105296541A (zh) * | 2014-07-30 | 2016-02-03 | 无限极（中国）有限公司 | 燕麦发酵液及其制备方法与作为化妆品原料的应用 |
| ES2575828B1 (es) * | 2014-12-31 | 2017-07-07 | Universidad De León | Empleo de probióticos en el incremento de la fertilidad masculina |
| GB201501938D0 (en) | 2015-02-05 | 2015-03-25 | Multigerm Uk Entpr Ltd | Probiotic preparation |
| CA3088630A1 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
| CN108315279A (zh) * | 2018-04-09 | 2018-07-24 | 河南科技大学 | 一种植物乳杆菌液体制剂的长时间储存方法 |
| CA3103064A1 (en) * | 2018-06-19 | 2019-12-26 | 4D Pharma Research Ltd | Dosage form comprising a live biotherapeutic product |
| JPWO2020013239A1 (ja) * | 2018-07-10 | 2021-05-13 | 学校法人慶應義塾 | Ｄ−プシコース応答性増殖能を有する腸内細菌 |
| US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| CA3111795A1 (en) | 2018-09-05 | 2020-03-12 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases |
| CN109486713B (zh) * | 2018-12-06 | 2021-03-09 | 福建傲农生物科技集团股份有限公司 | 一种液态复合乳酸杆菌制剂及其制备方法与应用 |
| GB201915144D0 (en) | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| WO2021113850A2 (en) * | 2019-12-06 | 2021-06-10 | Nas Bioventures Llc | Onsite installation or manufactured product of eco-friendly bacterial compositions, methods and systems for bioremediation in a short duration in different environments |
| JP2023533513A (ja) * | 2020-06-29 | 2023-08-03 | キャンバイオシン・インコーポレイテッド | 胃腸障害を有する伴侶動物を支援するための組成物および関連する方法 |
| WO2023092150A1 (en) | 2021-11-22 | 2023-05-25 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
| GB202210523D0 (en) | 2022-07-18 | 2022-08-31 | Multigerm Uk Entpr Ltd | Probiotic compositions and therapeutic uses thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB906212A (en) * | 1960-08-04 | 1962-09-19 | Lilly Co Eli | The antibiotic valacidin and its salts and methods for producing same |
| US3623956A (en) * | 1970-01-21 | 1971-11-30 | Rapidase Sa Soc | Preparation of microbial alkaline protease by fermentation with bacillus subtilis, variety licheniformis |
| US3846397A (en) * | 1970-04-06 | 1974-11-05 | J Ernster | Process for utilizing barley malt |
| US4464402A (en) * | 1978-04-24 | 1984-08-07 | F.I.N.D. Research Corporation | Process for manufacturing a high protein food material |
| US4275164A (en) * | 1979-11-05 | 1981-06-23 | Eastman Kodak Company | Process and nutrient medium for growing microorganism |
| EP0189657B1 (en) * | 1984-12-12 | 1989-03-01 | WHITBREAD & COMPANY PLC | A brewing process |
| JPS63273469A (ja) * | 1986-12-13 | 1988-11-10 | Kyowa Hakko Kogyo Co Ltd | 乳糖資化性を有する新規微生物 |
| DK686187D0 (da) | 1987-12-23 | 1987-12-23 | Hansens Chr Bio Syst | Veterinaert praeparat |
| JP2835894B2 (ja) * | 1991-07-26 | 1998-12-14 | 農林水産省食品総合研究所長 | ビフィズス菌増殖促進剤 |
| JPH08259450A (ja) * | 1995-03-17 | 1996-10-08 | Nichinichi Seiyaku Kk | インターフェロン産生増強剤 |
| IE960360A1 (en) * | 1996-05-23 | 1997-12-31 | Valdosa Limited | A brewing process |
| MXPA99001239A (es) * | 1996-08-05 | 2003-09-12 | Syngenta Mogen Bv | Proceso mejorado para la produccion de bebidas alcoholicas que utilizan semilla de malta. |
| US6811786B1 (en) | 1999-04-01 | 2004-11-02 | Ganeden Biotech, Inc. | Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions |
| FR2777424B1 (fr) * | 1998-04-15 | 2000-06-16 | Lesaffre & Cie | Levain panaire longue conservation pret a l'emploi |
| US6420146B1 (en) * | 2000-03-30 | 2002-07-16 | Council Of Scientific & Industrial Research | Process for the preparation of stable yeast crystals for enhanced production of ethanol |
| JP4424643B2 (ja) * | 2002-02-13 | 2010-03-03 | 株式会社バイオバンク | 抗真菌剤の製造方法 |
| GB2391554B (en) * | 2002-08-06 | 2005-09-14 | Heineken Ireland Ltd | A stout manufacturing process |
| GB2418431A (en) * | 2004-09-27 | 2006-03-29 | Multigerm Uk Entpr Ltd | Metabolically active micro organisms and methods for their production |
-
2004
- 2004-09-27 GB GB0421448A patent/GB2418431A/en not_active Withdrawn
-
2005
- 2005-09-27 PL PL16155521T patent/PL3050960T3/pl unknown
- 2005-09-27 NZ NZ553858A patent/NZ553858A/en not_active IP Right Cessation
- 2005-09-27 PL PL05786983.6T patent/PL1794283T3/pl unknown
- 2005-09-27 EP EP05786983.6A patent/EP1794283B1/en not_active Expired - Lifetime
- 2005-09-27 CN CNB2005800324851A patent/CN100537740C/zh not_active Expired - Lifetime
- 2005-09-27 CN CN2009101495392A patent/CN101603021B/zh not_active Expired - Lifetime
- 2005-09-27 EA EA200700613A patent/EA012968B1/ru not_active IP Right Cessation
- 2005-09-27 WO PCT/GB2005/003715 patent/WO2006035218A1/en not_active Ceased
- 2005-09-27 AU AU2005288751A patent/AU2005288751B2/en not_active Expired
- 2005-09-27 US US11/663,877 patent/US8551473B2/en active Active
- 2005-09-27 CA CA2580949A patent/CA2580949C/en active Active
- 2005-09-27 ES ES05786983.6T patent/ES2568955T3/es active Active
- 2005-09-27 EP EP16155521.4A patent/EP3050960B1/en not_active Expired - Lifetime
- 2005-09-27 JP JP2007532974A patent/JP5577020B2/ja not_active Expired - Lifetime
- 2005-09-27 ES ES16155521.4T patent/ES2654246T3/es active Active
-
2007
- 2007-03-22 ZA ZA200702398A patent/ZA200702398B/xx unknown
- 2007-04-27 NO NO20072210A patent/NO20072210L/no not_active Application Discontinuation
-
2012
- 2012-09-05 US US13/604,196 patent/US20130011368A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN101027387A (zh) | 2007-08-29 |
| JP5577020B2 (ja) | 2014-08-20 |
| US20110158949A1 (en) | 2011-06-30 |
| CN101603021B (zh) | 2013-04-24 |
| CA2580949C (en) | 2017-07-25 |
| CN100537740C (zh) | 2009-09-09 |
| GB0421448D0 (en) | 2004-10-27 |
| GB2418431A (en) | 2006-03-29 |
| CA2580949A1 (en) | 2006-04-06 |
| HK1134686A1 (en) | 2010-05-07 |
| WO2006035218A1 (en) | 2006-04-06 |
| JP2008514582A (ja) | 2008-05-08 |
| EP1794283B1 (en) | 2016-04-13 |
| NO20072210L (no) | 2007-04-27 |
| EP3050960A1 (en) | 2016-08-03 |
| PL1794283T3 (pl) | 2016-10-31 |
| NZ553858A (en) | 2009-01-31 |
| ES2654246T3 (es) | 2018-02-12 |
| PL3050960T3 (pl) | 2018-05-30 |
| AU2005288751A1 (en) | 2006-04-06 |
| AU2005288751B2 (en) | 2010-12-23 |
| ZA200702398B (en) | 2008-10-29 |
| US20130011368A1 (en) | 2013-01-10 |
| EA200700613A1 (ru) | 2007-10-26 |
| CN101603021A (zh) | 2009-12-16 |
| EP3050960B1 (en) | 2017-12-13 |
| EP1794283A1 (en) | 2007-06-13 |
| US8551473B2 (en) | 2013-10-08 |
| EA012968B1 (ru) | 2010-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2568955T3 (es) | Microorganismos metabólicamente activos y métodos para su producción | |
| ES2324532T3 (es) | Bacteria probiotica: lactobacillus fermentum. | |
| US20100166721A1 (en) | Probotic compositions and uses thereof | |
| US20110165127A1 (en) | Dairy-derived probiotic compositions and uses thereof | |
| ES2545209T3 (es) | Método de obtención de una nueva cepa de Bifidobacterium bifidum con actividad frente a la infección por Helicobacter pylori | |
| KR20120047792A (ko) | 항균용 유산균 사균체 및 이의 제조방법 | |
| WO2014068338A1 (en) | Diverticulitis treatment | |
| US20140314719A1 (en) | IBS Treatment | |
| CN109929779A (zh) | 一种含有生物活性肽的益生菌制剂及其制备方法和应用 | |
| KR101000364B1 (ko) | 생존율 증강용 이중 코팅 방법 | |
| ES2963547T3 (es) | Tratamiento del IBS con probióticos | |
| Matarese et al. | The role of probiotics in gastrointestinal disease | |
| RU2257408C1 (ru) | Лечебно-профилактический биопрепарат на основе сухой биомассы бифидо- и лактобактерий, биологически активная добавка к пище на основе сухой биомассы бифидо- и лактобактерий, сухая биомасса бифидо- и лактобактерий и способ ее получения | |
| RU2253672C2 (ru) | Бактериальный пробиотический препарат | |
| BR102022021803A2 (pt) | Processo de produção e aplicação de metabólitos de probióticos na inibição de microrganismos patogênicos | |
| HK1134686B (en) | Metabolically active micro organisms and methods for their production | |
| LT5578B (lt) | Maistinio arba farmacinio biopreparato kompozicija | |
| KR20180011824A (ko) | 소화장관 전달효율이 증진된 경구투여용 가축용 생균제 타블렛 및 그 제조방법 |